Anti-Podoplanin Antibody

A1564-100

Anti-Podoplanin Antibody

1012.2 €

HA500364

Anti-Podoplanin Antibody

Mediates effects on cell migration and adhesion through its different partners. During development plays a role in blood and lymphatic vessels separation by binding CLEC1B, triggering CLEC1B activation in platelets and leading to platelet activation and/or aggregation.Interaction with CD9, on the contrary, attenuates platelet aggregation induced by PDPN. Through MSN or EZR interaction promotes epithelial-mesenchymal transition (EMT) leading to ERZ phosphorylation and triggering RHOA activation leading to cell migration increase and invasiveness. Interaction with CD44 promotes directional cell migration in epithelial and tumor cells. In lymph nodes (LNs), controls fibroblastic reticular cells (FRCs) adhesion to the extracellular matrix (ECM) and contraction of the actomyosin by maintaining ERM proteins (EZR; MSN and RDX) and MYL9 activation through association with unknown transmembrane proteins. Engagement of CLEC1B by PDPN promotes FRCs relaxation by blocking lateral membrane interactions leading to reduction of ERM proteins (EZR; MSN and RDX) and MYL9 activation. Through binding with LGALS8 may participate in connection of the lymphatic endothelium to the surrounding extracellular matrix. In keratinocytes, induces changes in cell morphology showing an elongated shape, numerous membrane protrusions, major reorganization of the actin cytoskeleton, increased motility and decreased cell adhesion.

433.5 €

MBS4156562-01mg

Anti-Podoplanin Antibody

593 €

PA1411

Anti-Podoplanin/gp36/PDPN Antibody

Western blot, 0.1-0.5μg/ml, Human

381 €

PA1674

Anti-Podoplanin/gp36/PDPN Antibody

679.2 €

PA1675

Anti-Podoplanin/gp36/PDPN Antibody

Western blot, 0.1-0.5μg/ml, Mouse, Rat

381 €